Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Katherine J. Lepik"'
Autor:
Lalani L. Munasinghe, Junine Toy, Katherine J. Lepik, David M. Moore, Mark Hull, Nic Bacani, Paul Sereda, Rolando Barrios, Julio S. G. Montaner, Viviane D. Lima
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
In 2018, the pre-exposure prophylaxis (PrEP) program was initiated in British Columbia (BC), Canada, providing PrEP at no cost to qualifying residents. This observational study discussed the steps to develop key evidence-based monitoring indicators a
Externí odkaz:
https://doaj.org/article/5962ed4579684f39bd3dff372f29d5d0
Autor:
David M. Moore, Hayden Kremer, Lu Wang, Katherine J. Lepik, Jenny Li, Kate Salters, Julio S. G. Montaner, Clara Tam, Rakel Kling, Aamir Bharmal, Karin Goodison, Tatiana Pakhomova, Rolando Barrios
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 90:33-40
In 2016, the British Columbia HIV/AIDS Drug Treatment Program modified its prescriber alert system for antiretroviral therapy (ART) interruptions to include referrals to regional public health nursing teams for direct outreach support for those who r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa3a0dbdf28c2b83ffaffd0db5002b9
https://doi.org/10.1097/qai.0000000000002914
https://doi.org/10.1097/qai.0000000000002914
Autor:
Peter K. Cheung, Aniqa Shahid, Winnie Dong, Katherine J. Lepik, Julio S. G. Montaner, Mark A. Brockman, Zabrina L. Brumme, Chanson J. Brumme
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:979-988
Background Routine HIV drug resistance genotyping identified an integrase sequence harbouring T97A, E138K, G140S and Q148H, with high predicted resistance to all integrase strand transfer inhibitors (INSTIs). Objectives To assess the impact of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7186aa906bc83073e6a79461d333fc1
https://doi.org/10.1093/jac/dkab498
https://doi.org/10.1093/jac/dkab498
Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada
Autor:
Katherine J. Lepik, Lu Wang, Marianne Harris, Taylor McLinden, Sidhant Guliani, Linda Akagi, Junine Toy, Paul Sereda, Viviane D. Lima, Julio S.G. Montaner, Rolando Barrios
Publikováno v:
AIDS (London, England). 36(8)
To characterize the annual prevalence of antiretroviral/nonantiretroviral drug interactions in relation to antiretroviral therapy (ART)-prescribing patterns, and to describe drug interaction-related ART changes.This cohort study included ART-treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd9d565046b0a9b719e6d3c0a9cddc23
https://pubmed.ncbi.nlm.nih.gov/35285822
https://pubmed.ncbi.nlm.nih.gov/35285822
Autor:
Chanson J. Brumme, Junine Toy, Kieran Atkinson, Paul Sereda, Rolando Barrios, Kathleen Auyeung, Katherine A Baynes, Katherine J. Lepik, Birgit Watson
Publikováno v:
Therapeutic drug monitoring. 43(5)
Background In British Columbia, antiretrovirals are distributed at no cost to patients via a publicly funded program, using generic formulations if available. A generic efavirenz-emtricitabine-tenofovir DF (EFV-FTC-TDF) combination pill became availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f620ef290e31f64cb686d5895953d8a
https://pubmed.ncbi.nlm.nih.gov/33560098
https://pubmed.ncbi.nlm.nih.gov/33560098
Autor:
Jenny B.W. Li, Kate Salters, Rolando Barrios, David Moore, Katherine J. Lepik, Lu Wang, Jon Kremer, Karen Slakov
Publikováno v:
Poster Presentations.
Background In mid-2016, the BC HIV Drug Treatment Program (DTP) expanded its province-wide prescriber alert system for ART interruptions to include direct referrals to public health offices for persons off treatment for >4 months. We examined outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b36bfcb78e06e66229c102f2ff05b6e
https://doi.org/10.1136/sextrans-2019-sti.424
https://doi.org/10.1136/sextrans-2019-sti.424
Autor:
Conan K. Woods, Marjorie Robbins, P. Richard Harrigan, Kimia Kamelian, Jeffrey B. Joy, Rolando Barrios, Benita Yip, Viviane D. Lima, Andrea D. Olmstead, Katherine J. Lepik, Wendy Zhang, William Chau
Publikováno v:
Open Forum Infectious Diseases
BackgroundIntegrase strand transfer inhibitors (INSTIs) are highly efficacious and well tolerated antiretrovirals with fewer adverse side-effects relative to other classes of antiretrovirals. The use of INSTIs raltegravir, elvitegravir, and dolutegra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e43713499b2cbe36c17e6b9de5ad33b
https://doi.org/10.1093/ofid/ofz060
https://doi.org/10.1093/ofid/ofz060
Autor:
Ana C. Ulloa, Silvia Guillemi, Julio S. G. Montaner, Benita Yip, Viviane D. Lima, Linda Akagi, Junine Toy, Katherine J. Lepik, Rolando Barrios, Lu Wang
Publikováno v:
AIDS (London, England). 32(7)
Objectives To describe and compare integrase strand transfer inhibitor (INSTI) adverse drug reactions (ADRs) for raltegravir, elvitegravir-cobicistat, and dolutegravir. Design Population-based, retrospective cohort. Methods Antiretroviral-experienced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd258cacd74a5b916d5f074a17332855
https://pubmed.ncbi.nlm.nih.gov/29424784
https://pubmed.ncbi.nlm.nih.gov/29424784
Autor:
Treena Orchard, Warren Michelow, Robert S. Hogg, Katherine J. Lepik, Alexis K. Palmer, Kate Salters
Publikováno v:
Critical Public Health. 26:542-553
People with drug addictions have among the lowest rates of adherence to HIV medications (i.e. HAART) of any infected population, which is often explained through reference to the instability associated with problematic drug use and the ‘chaos’ th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9296ea196b94301d686692dba5031fca
https://doi.org/10.1080/09581596.2015.1088641
https://doi.org/10.1080/09581596.2015.1088641
Autor:
Rolando Barrios, W. Chau, Adriana Nohpal, S. Kesselring, Viviane D. Lima, Hasina Samji, Lillian Lourenço, Robert S. Hogg, David M. Moore, Katherine J. Lepik, G. Colley, J. S. G. Montaner
Publikováno v:
HIV Medicine. 16:337-345
Objectives The aim of the study was to examine trends in initiating highly active antiretroviral therapy (HAART) with a CD4 count ≤ 200 cells/μL and the contribution of having a CD4 count ≤ 200 cells/μL at the time of diagnosis to these trends,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720b1f2943cae04f7507ae22fb7f0c5f
https://doi.org/10.1111/hiv.12212
https://doi.org/10.1111/hiv.12212